Prescribing Exercise in Early-Stage Breast Cancer During Chemotherapy: A Simple Periodized Approach to Align With the Cyclic Phases of Chemotherapy. Issue 10 (26th October 2022)

• Record Type: Journal Article
• Authors: Bigaran, Ashley; Howden, Erin J.; Foulkes, Steve; Janssens, Kristel; Beaudry, Rhys I.; Haykowsky, Mark J.; La Gerche, Andre; Fraser, Steve F.; Selig, Steve E.
• Is Part Of: Journal of strength and conditioning research. Volume 36:Issue 10(2022)
• Page Start: 2934
• Page End: 2941
• Publication Date: 2022-10-26
• Subjects: exercise training -- training load -- periodization -- adherence -- oncology; Physical education and training -- Periodicals; Weight training -- Physiological aspects -- Periodicals; Physical fitness -- Periodicals; 613.7
• DOI: 10.1519/JSC.0000000000003990
• Languages: English
• ISSNs: 1064-8011

Abstract

Abstract : Supplemental Digital Content is Available in the Text. Abstract: Bigaran, A, Howden, EJ, Foulkes, S, Janssens, K, Beaudry, R, Haykowsky, MJ, La Gerche, A, Fraser, SF, and Selig, SE. Prescribing exercise in early-stage breast cancer during chemotherapy: a simple periodized approach to align with the cyclic phases of chemotherapy. J Strength Cond Res 36(10): 2934–2941, 2022—To evaluate whether a periodized aerobic and resistance training plan aligned to the anthracycline chemotherapy (AC) cycles would be well tolerated, feasible, and attenuate the decline in peak oxygen uptake (V̇o 2 peak) in breast cancer (BC) patients. Twenty-eight women with early-stage BC treated with AC self-selected to undertake exercise training (EX 47 ± 9 years, n = 14) or usual care (53 ± 9 years, n = 14) for 12 weeks as part of a nonrandomized controlled trial. The periodized EX was aligned to the cyclic phases of AC, including AC taper and nontaper weeks. Outcome measures included cardiopulmonary exercise testing. Attendance and adherence variables (relative dose intensity [RDI] and volume load) were calculated to quantify the dose of EX completed relative to the amount of EX prescribed. The mean session attendance was 76% (range 46–88%). The mean ± SD prescribed and completed dose of aerobic training was 332.3 ± 48.7 MET h·wk −1 and 380.6 ± 53.2 MET h·wk −1 ( p = 0.02), equating to a mean RDI of 89 ± 17%. For resistance training, the prescribed and completed cumulative dose was 128, 264 ± 54, 578 and 77, 487 ± 26, 108 kg ( p < 0.001), equating to an RDI of 60 ± 11%. Adherence to the AC taper week RDI (52 ± 14%) for resistance training was significantly lower than the non-AC taper week (72 ± 8%, p = 0.02). The most frequent cause for EX interruption was hospitalization (35%), whereas AC-related illness was the most common cause for missed (57%) or modified EX sessions (64%). This periodized approach was mostly well tolerated for patients with BC. We speculate that a periodized approach may be both more palatable and useful, although this requires further investigation in a randomized controlled trial.